Literature DB >> 19489689

Folate receptor-targeted quantum dot liposomes as fluorescence probes.

Chang Yang1, Nan Ding, Yibing Xu, Xiaolan Qu, Jing Zhang, Chaoyang Zhao, Liang Hong, Yao Lu, Guangya Xiang.   

Abstract

In this study, the preparation of the novel imaging agents, folate receptor (FR)-targeted liposomes encapsulating hydrophilic CdTe quantum dots (QDs), and their use as luminescence probes for live cell imaging are reported. Hydrophilic CdTe QDs were directly synthesized in the water phase, and FR-targeted QD liposomes were prepared by hydrating the lipid thin film with CdTe suspension. Formulations were characterized by UV-visible and fluorescent measurements, liposomal particle size, and zeta potential. The targeting and imaging ability of FR-targeted liposomes were investigated against the human uterine cervix cancer cell line (HeLa). Furthermore, the cytotoxicity of QD liposomes was evaluated by HeLa cells incubated with FR-targeted QD liposomes, nontargeted QD liposomes, and free QDs. The results showed that FR-targeted QD liposomes were spherically shaped with high fluorescence yield, excellent photochemical stability, good cancer targeting, and minimal cytotoxicity. The average size of FR-targeted fluorescence liposomes was ~105 nm, and their size distribution was rather narrow. After storage at 4 degrees C for 11 months, QD liposomes maintained similar size and did not show any leakage of QDs. FR-targeted CdTe QD liposomes, which can target tumor cells via FR-mediated endocytosis, would become an attractive probe for tumor cell or tissue imaging for a long-time monitoring.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489689     DOI: 10.1080/10611860903013248

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  7 in total

Review 1.  Fluorescent molecular imaging: technical progress and current preclinical and clinical applications in urogynecologic diseases.

Authors:  V M Alexander; P L Choyke; H Kobayashi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 2.  Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.

Authors:  Anish Babu; Amanda K Templeton; Anupama Munshi; Rajagopal Ramesh
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

3.  Fluorescence imaging agents in cancerology.

Authors:  Aurélie Paganin-Gioanni; Elisabeth Bellard; Laurent Paquereau; Vincent Ecochard; Muriel Golzio; Justin Teissié
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

4.  Entrapment in phospholipid vesicles quenches photoactivity of quantum dots.

Authors:  Roman Generalov; Simona Kavaliauskiene; Sara Westrøm; Wei Chen; Solveig Kristensen; Petras Juzenas
Journal:  Int J Nanomedicine       Date:  2011-09-07

5.  Folic acid-CdTe quantum dot conjugates and their applications for cancer cell targeting.

Authors:  Preethi Suriamoorthy; Xing Zhang; Guiyang Hao; Alan G Joly; Surya Singh; Marius Hossu; Xiankai Sun; Wei Chen
Journal:  Cancer Nanotechnol       Date:  2010-07-31

6.  Utilizing the folate receptor for active targeting of cancer nanotherapeutics.

Authors:  Grant L Zwicke; G Ali Mansoori; Constance J Jeffery
Journal:  Nano Rev       Date:  2012-12-07

Review 7.  Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy.

Authors:  Pan Liang; Linshen Mao; Yanli Dong; Zhenwen Zhao; Qin Sun; Maryam Mazhar; Yining Ma; Sijin Yang; Wei Ren
Journal:  Pharmaceutics       Date:  2021-12-03       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.